Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
NCT ID: NCT01644981
Last Updated: 2016-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2012-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers and Volumetric Capnography in BPD
NCT02083562
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
NCT01516398
Ultrasound Assessment of Diaphragmatic Function in Infants With BPD
NCT04941963
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
NCT04756297
Pulmonary Hypertension in Extremely Preterm Infants
NCT05136235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VLBW infants
blood sampling
blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sampling
blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Weeks
4 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital Basel
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven Wellmann, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Division of Neonatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Division of Neonatology
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.3 07.10.2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.